 Vancouver, British Columbia and Minneapolis, Minnesota--Newsfile Corp. - December 15, 2020 - Neovasc Inc. NASDAQ: NVCN TSX: NVCN Neovasc or the Company announced today that it has completed the first three Neovasc ReducerTM Reducer implants in France. The implants are an important step for Neovasc as the Company continues to expand access for Reducer therapy to patients suffering from refractory angina.The implants were conducted by Prof. Martine Gilard, Director of Interventional Cardiology, and Prof. Romain... 